Insider Transactions in Q3 2023 at Syros Pharmaceuticals, Inc. (SYRS)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 16
2023
|
Srinivas Akkaraju |
BUY
Exercise of conversion of derivative security
|
Direct |
2,666
+50.0%
|
-
|
|
Sep 16
2023
|
Mark J Alles Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,666
+42.1%
|
-
|
|
Sep 16
2023
|
Richard A Young |
BUY
Exercise of conversion of derivative security
|
Direct |
2,666
+6.42%
|
-
|
|
Jul 31
2023
|
David Roth Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,348
-100.0%
|
$22,044
$3.95 P/Share
|
|
Jul 17
2023
|
Eric R Olson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
689
-9.37%
|
$2,067
$3.5 P/Share
|